Compile Data Set for Download or QSAR
maximum 50k data
Found 294 with Last Name = 'mallart' and Initial = 's'
TargetRelaxin receptor 1(Homo sapiens (Human))
Sanofi R&D

Curated by ChEMBL
LigandPNGBDBM50563230(CHEMBL4754949)
Affinity DataKi:  1.10nMAssay Description:Displacement of Eu3+-labelled H2 relaxin from human RXFP1 expressed in human HEK-293T cells in presence of 10 % FCS by competition binding assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetRelaxin receptor 1(Homo sapiens (Human))
Sanofi R&D

Curated by ChEMBL
LigandPNGBDBM50563231(CHEMBL4780098)
Affinity DataKi:  2.88E+3nMAssay Description:Displacement of Eu3+-labelled H2 relaxin from human RXFP1 expressed in human HEK-293T cells in presence of 10 % FCS by competition binding assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM175246(US9115140, I-26)
Affinity DataIC50:  0.5nMAssay Description:The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM175251(US9115140, I-123)
Affinity DataIC50:  0.5nMAssay Description:The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetALK tyrosine kinase receptor [L1196M](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM175253(US9115140, I-131)
Affinity DataIC50:  1nMAssay Description:The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCoagulation factor X(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183069(US9150544, 103)
Affinity DataIC50:  1.40nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 然 final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM175250(US9115140, I-118)
Affinity DataIC50:  2nMAssay Description:The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCoagulation factor X(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM182990(US9150544, 24)
Affinity DataIC50:  2nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 然 final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetALK tyrosine kinase receptor [L1196M](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM175250(US9115140, I-118)
Affinity DataIC50:  2nMAssay Description:The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM175248(US9115140, I-100)
Affinity DataIC50:  3nMAssay Description:The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM175253(US9115140, I-131)
Affinity DataIC50:  3nMAssay Description:The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetALK tyrosine kinase receptor [L1196M](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM175248(US9115140, I-100)
Affinity DataIC50:  3nMAssay Description:The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetALK tyrosine kinase receptor [L1196M](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM175251(US9115140, I-123)
Affinity DataIC50:  4nMAssay Description:The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCoagulation factor X(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM182980(US9150544, 14)
Affinity DataIC50:  4nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 然 final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM175255(US9115140, I-159)
Affinity DataIC50:  4nMAssay Description:The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCoagulation factor X(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183016(US9150544, 50)
Affinity DataIC50:  5nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 然 final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCoagulation factor X(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183014(US9150544, 48)
Affinity DataIC50:  6.40nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 然 final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM175247(US9115140, I-38)
Affinity DataIC50:  7nMAssay Description:The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM175245(US9115140, I-16)
Affinity DataIC50:  7nMAssay Description:The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCoagulation factor X(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM182987(US9150544, 21)
Affinity DataIC50:  8nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 然 final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM175257(US9115140, I-172)
Affinity DataIC50:  8nMAssay Description:The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCoagulation factor X(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183012(US9150544, 46)
Affinity DataIC50:  8.40nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 然 final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetALK tyrosine kinase receptor [L1196M](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM175255(US9115140, I-159)
Affinity DataIC50:  9nMAssay Description:The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCoagulation factor X(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM182996(US9150544, 30)
Affinity DataIC50:  12nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 然 final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetALK tyrosine kinase receptor [L1196M](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM175257(US9115140, I-172)
Affinity DataIC50:  13nMAssay Description:The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM175249(US9115140, I-115)
Affinity DataIC50:  13nMAssay Description:The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCoagulation factor X(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183010(US9150544, 44)
Affinity DataIC50:  14nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 然 final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM175244(US9115140, I-13)
Affinity DataIC50:  14nMAssay Description:The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetALK tyrosine kinase receptor [L1196M](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM60576(US9115140, I-191)
Affinity DataIC50:  14nMAssay Description:The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCoagulation factor X(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183028(US9150544, 62)
Affinity DataIC50:  16nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 然 final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM175254(US9115140, I-132)
Affinity DataIC50:  17nMAssay Description:The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCoagulation factor X(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM182983(US9150544, 17)
Affinity DataIC50:  17nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 然 final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetALK tyrosine kinase receptor [L1196M](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM175249(US9115140, I-115)
Affinity DataIC50:  17nMAssay Description:The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCoagulation factor X(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183058(US9150544, 92)
Affinity DataIC50:  19nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 然 final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCoagulation factor X(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM182979(US9150544, 13)
Affinity DataIC50:  21nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 然 final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCoagulation factor X(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM182977(US9150544, 11)
Affinity DataIC50:  21nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 然 final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCoagulation factor X(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183006(US9150544, 40)
Affinity DataIC50:  22nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 然 final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM175258(US9115140, I-176)
Affinity DataIC50:  23nMAssay Description:The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCoagulation factor X(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183061(US9150544, 95)
Affinity DataIC50:  25nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 然 final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCoagulation factor X(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183019(US9150544, 53)
Affinity DataIC50:  27nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 然 final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM175260(US9115140, I-202)
Affinity DataIC50:  27nMAssay Description:The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM175243(US9115140, I-7)
Affinity DataIC50:  28nMAssay Description:The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetALK tyrosine kinase receptor [L1196M](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM175260(US9115140, I-202)
Affinity DataIC50:  29nMAssay Description:The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCoagulation factor X(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM182975(US9150544, 9)
Affinity DataIC50:  29nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 然 final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCoagulation factor X(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM60667(BDBM183000 | US9150544, 34)
Affinity DataIC50:  32nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 然 final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCoagulation factor X(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM60667(BDBM183000 | US9150544, 34)
Affinity DataIC50:  32nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 然 final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCoagulation factor X(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183045(US9150544, 79)
Affinity DataIC50:  33nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 然 final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCoagulation factor X(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM182994(US9150544, 28)
Affinity DataIC50:  34nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 然 final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCoagulation factor X(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183026(US9150544, 60)
Affinity DataIC50:  34nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 然 final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM175256(US9115140, I-164)
Affinity DataIC50:  35nMAssay Description:The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0....More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 294 total ) | Next | Last >>
Jump to: